Võrdle meetodeid
Vaata valitud meetodeid kõrvuti; erinevad read on esile tõstetud.
| Masinõppimisega täiustatud entroopiabilansseerimine× | Kalduvusskoori sobitamine× | |
|---|---|---|
| Valdkond≠ | Põhjuslik järeldamine | Uurimisstatistika |
| Perekond≠ | Regression model | Process / pipeline |
| Tekkeaasta≠ | 2012-2017 | 1983 |
| Looja≠ | Hainmueller (2012) for entropy balancing; ML augmentation developed by Zhao & Percival (2017) and subsequent literature | Paul Rosenbaum and Donald Rubin |
| Tüüp≠ | Weighting-based causal estimator | Method |
| Algallikas≠ | Hainmueller, J. (2012). Entropy balancing for causal effects: A multivariate reweighting method to produce balanced samples in observational studies. Political Analysis, 20(1), 25-46. DOI ↗ | Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗ |
| Rööpnimetused≠ | ML-EB, augmented entropy balancing, ML-augmented EB, doubly-robust entropy balancing | PSM, propensity score weighting, covariate balance |
| Seotud≠ | 4 | 3 |
| Kokkuvõte≠ | Machine learning-augmented entropy balancing (ML-EB) combines Hainmueller's entropy balancing reweighting scheme with a machine-learning outcome model to produce a doubly-robust causal estimator. By jointly optimising covariate balance weights and a flexible predicted-outcome adjustment, ML-EB delivers consistent treatment-effect estimates even when either the weighting or the outcome model is misspecified, and it handles high-dimensional covariate spaces that classical entropy balancing cannot easily balance. | Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias. |
| ScholarGateAndmestik ↗ |
|
|